Exane Derivatives’s Health Catalyst HCAT Stock Holding History

Exane Derivatives’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$623	Hold	43	–	–	﹤0.01%	551
2022 Q1	$1.12K	Hold	43	–	–	﹤0.01%	797
2021 Q4	$1.7K	Sell	43 -2	-4%	-$91	﹤0.01%	671
2021 Q3	$2.25K	Hold	45	–	–	﹤0.01%	795
2021 Q2	$2.51K	Sell	45 -43	-49%	-$2.29K	﹤0.01%	805
2021 Q1	$4.12K	Buy	88 +13	+17%	+$630	﹤0.01%	632
2020 Q4	$3.27K	Buy	+75	New	+$2.77K	﹤0.01%	586

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Exane Derivatives's HCAT Position: Q2 2022 in Review

Exane Derivatives held its Health Catalyst (HCAT) position steady in Q2 2022 at 43 shares worth $623. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Exane Derivatives first reported a position in HCAT in Q4 2020 and has held it in 7 quarters since. The position peaked at $4.12K in Q1 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

Exane Derivatives held 43 shares of Health Catalyst worth $623 as of Q2 2022.
Exane Derivatives left its Health Catalyst share count unchanged in Q2 2022.
Health Catalyst made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #551 holding.
Exane Derivatives first reported a position in Health Catalyst in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Health Catalyst position peaked at $4.12K in Q1 2021.
179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.